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ABSTRACT 
We conducted a prospective observational study comparing salivary lactoferrin and 
lysozyme concentration over five months (chronic changes) in elite rowers (n=17, mean 
age 24.3 ± 4.0y) with sedentary individuals (controls) (n=18, mean age = 27.2 ± 7.1 y) 
and a graded exercise test to exhaustion (acute changes) with a cohort of elite rowers 
(n=11, mean age 24.7 ± 4.1). Magnitudes of differences and changes were interpreted as 
a standardized (Cohen’s) effect size (ES). Lactoferrin concentration in the observational 
study was approximately 60% lower in rowers than control subjects at baseline (7.9 ± 1.2 
µg.ml-1 mean ± SEM, 19.4 ± 5.6 µg.ml-1, P=0.05, ES=0.68, ‘moderate’) and at the 
midpoint of the season (6.4 ± 1.4 µg.ml-1 mean ± SEM, 21.5 ± 4.2 µg.ml-1, P=0.001, 
ES=0.89, ‘moderate’). The concentration of lactoferrin at the end of the study was not 
statistically significant (P=0.1) between the groups. There was no significant difference 
between rowers and control subjects in lysozyme concentration during the study. There 
was a 50% increase in the concentration of lactoferrin (P=0.05, ES=1.04, ‘moderate’) and 
55% increase in lysozyme (P=0.01, ES=3.0, ‘very large’) from pre-exercise to exhaustion 
in the graded exercise session. Lower concentrations of these proteins may be indicative 
of an impairment of innate protection of the upper respiratory tract. Increased salivary 
lactoferrin and lysozyme concentration following exhaustive exercise may be due to a 
transient activation response that increases protection in the immediate post exercise 
period. 
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INTRODUCTION 
Athletes undertaking prolonged intense exercise, particularly elite athletes, may suffer a 
higher incidence of URTI than individuals participating in moderate exercise or no 
exercise at all1, 2. While the results have been inconclusive, athletes who remain free of 
illness immediately prior to and during competition are likely to perform better than their 
peers with illness3. Immune resilience is an important factor in success at the elite level4 
and underpins efforts to understand the mechanisms that regulate susceptibility to illness 
from exercise.  
 
There have been few investigations into the effect of exercise on innate mucosal immune 
secretions, particularly antimicrobial proteins (AMPs). AMPs are small cationic proteins 
that are constituent and inducible factors of mucosal secretions. Two of the most 
abundant AMPs in mucosal secretions of the upper respiratory tract (URT) are lactoferrin 
and lysozyme and both act directly against pathogenic organisms5. There is increasing 
interest in the role these proteins play in protecting the body from illness5, 6.  
 
Measurement of AMPs have been proposed for use as a diagnostic marker of mucosal 
immune status6, 7. A preliminary study by our group indicates that prolonged intense 
training can elicit a reduction in the concentration of salivary lactoferrin at the onset of a 
training season, which may be an adaptive response to exercise8. A short duration, 
incremental exercise test to exhaustion and a short duration exercise session at 75% 
VO2max resulted in a transient increase in the concentration of salivary lysozyme without 
affecting salivary flow rate7. This contrasts with a significant decrease in salivary 
lysozyme reported following an intense training session in elite swimmers9. 
 
The aim of this study was to further our understanding of the relationship between 
exercise and innate immunity by describing the timecourse and magnitude of changes in 
the concentration of salivary lactoferrin and lysozyme in elite rowers over a five-month 
training season. A second aim was to quantify the time course of acute changes in 
salivary lactoferrin and lysozyme in response to sub-maximal and maximal exercise.  
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MATERIAL AND METHODS 
Study design 
The prospective observational study ran for five months as a cohort of elite rowers 
prepared for selection to the Australian Rowing Team. Differences in lactoferrin and 
lysozyme were assessed between the rowers and a sedentary control group at baseline, 
the midpoint of the training period and at the completion of the training period. A sub-
group of rowers completed a progressive rowing ergometer text to exhaustion to assess 
the impact of submaximal and maximal exercise loads on salivary AMP concentration 
under controlled conditions in the laboratory. The control group did not undergo the 
incremental test to exhaustion as the study did not seek to directly compare whether there 
was a difference in the response of antimicrobial proteins between elite athletes and 
sedentary individuals to submaximal and maximal exercise. 
 
Subjects 
There were 17 elite rowers (eight male, ages 25.9±4.0y, VO2max 5.4 ± 0.4 ml.kg-1.min-1, 
nine female, ages 23.8±VO2max 4.2 ± 0.3 ml.kg-1.min-1) that participated in the 
longitudinal study. A sedentary control group consisting of eight males and nine females 
(age = 27.3±7.2y) was also recruited and were restricted to five hours physical activity 
per week based on physical activity guidelines from the National Physical Activity 
Guidelines (NPAG) and surveys reporting physical activity levels of the Australian 
Community10, 11. A sub-group of 11 elite rowers (four male, age = 27.0±5.4y, VO2max 
5.6±0.7ml.kg-1.min-1, seven female, age 23.5±2.8y, VO2max 4.9±0.3ml.kg-1.min-1) 
participated in the rowing ergometer test. All subjects were screened for use of 
immunomodulating medications before inclusion in the project. The study was approved 
by the Griffith University Human Research Ethics Committee and the AIS Ethics 
Committee and all participants provided written informed consent. 
 
Saliva collection 
 In the observational study samples were taken every two weeks from the rowers prior to 
an afternoon training session and from the control subjects at baseline, at the mid-point, 
and the end of the study. All saliva samples in the observational study were taken at the 
same time of the day to control for diurnal variation and at least one hour post prandial. 
Saliva samples in the rowing ergometer test were taken pre test, following a moderate 
exercise load and after a maximal step to exhaustion. The moderate exercise load was 
determined as the point that blood lactate reached 4mM.  Saliva samples were collected 
using an eye spear (Defries Industies Pty Ltd, Victoria, Australia), which was placed 
between the cheek and teeth for up to five minutes. All samples were frozen at minus 
80°C until analysis. Albumin concentration was assessed to control for changes in 
salivary flow rate. 
 
Training program 
The training program undertaken was a periodised program designed by AIS coaches. 
The training program had three distinct phases, an initial endurance phase characterized 
by high volume and low intensity, a mid-season quality phase of moderate volume and 
high intensity training, and a taper phase leading into the selection events. An outline of 
the training program corresponding to weeks 4 to 11 in the longitudinal study is shown in 
Figure 1. No training details were available for the initial three weeks of the study, from 
late December to early January. The athletes maintained a daily illness log that recorded 
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the details for the sessions undertaken to allow comparison to the designed training 
program. 
 
Submaximal and Maximal Effort Rowing Test 
This rowing ergometer test involves the completion of several steps, each of four minutes 
duration at increasing intensity and with each step separated by a one minute recovery 
interval. The graded exercise test has been described in detail previously12.  Each subject 
completed the number of steps required to reach 4 mM lactate in blood or until seven 
steps was attained. 4 mM is a commonly utilised approximation of the mean lactate 
steady state and was therefore nominated as the submaximal workload. Once blood 
lactate reached 4 mM or the rower has completed seven steps the athlete had a 20 minute 
rest period before completing an Olympic distance step at maximal exertion. A series of 
calculations based on the subject’s best previous 2000 metre rowing ergometer time was 
used to individualise the workload for the steps undertaken until blood lactate reaches 
four mM. 
 
Lactoferrin, lysozyme and albumin assays 
The concentration of salivary lactoferrin and lysozyme was measured in duplicate using a 
commercial ELISA assay kits (lactoferrin - Calbiochem, Darmstadt, Germany and 
lysozyme - ImmuneDiagnostik, Bensheim, Germany) according to the manufacturer’s 
instructions. All saliva samples were centrifuged before analysis.  The following dilutions 
were made: lactoferrin 1:600 rowers and 1:800 controls; lysozyme 1:1500  rowers and 
1:3000 controls to produce values within the standard curve. Dilution factors were 
optimized for each group to ensure an acceptable goodness of fit to the standard curve. 
The concentration of both proteins was measured colorimetrically at 450nm on a BioRad 
Model 3550 Microplate Reader (Bio-Rad, California, USA). All samples were analysed 
in a single batch to reduce the variability of the measurements. The between-run 
coefficient of variation (CV) was 8.8% for lactoferrin and 9.9% for lysozyme which are 
similar to levels reported previously13. Albumin concentration was measured using a 
commercial albumin kit (Roche/Hitachi, Mannheim, Germany) on a Hitachi 911 analyser 
(Hitachi, Boehringer, Mannheim, Germany). Each sample was diluted 1:10. The 
sensitivity range on the test is from 3-400mg/L.  
 
Statistical analysis 
Data was log-transformed as is usual practice for immunological measures in saliva. Data 
is presented as mean ± standard error of the mean. The primary analysis involved a 
comparison of the change in mean differences between the athlete and control groups 
using an independent t-test with unequal variance. The repeated measures analysis of 
fortnightly changes in lactoferrin and lysozyme in the rowers was undertaken by 
comparing the change in the means between the experimental and control groups14. For 
the rowing ergometer test a pair-wise comparison of the pre-, mid-, and post-exercise 
sampling points was conducted using an independent t-test.  We used the approach of 
controlled trial analysis outlined by Batterham15.  The magnitudes of changes in AMP 
concentration were expressed as a standardized mean (Cohens) difference (difference in 
means divided by the between-subject standard deviation). The criteria to interpret the 
magnitude of the effect sizes were: <0.2 trivial, 0.2-0.6 small, 0.6-1.2 moderate, 1.2-2.0 
large and >2.0 very large. Significance was accepted at the level P<0.05. To compare the 
magnitude of variation in lactoferrin and lysozyme concentrations between the rowers 
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and controls we divided the between-subject coefficient of variations (CV).  Ratios within 
a range of 0.9-1.1 were considered trivial (see justification at 
http://yahoogroups.com/groups/sportscience/message/2538). Ratios >1.1 indicate AMP 
concentrations were substantially more variable for the rowers, whereas ratios <0.9 
indicates AMP concentrations were substantially less variable for the rowers than the 
control subjects.  
 
RESULTS 
Mean concentration of lactoferrin in saliva 
The mean concentration and standard error of the mean for salivary lactoferrin in the 
control subjects and the rowers is shown in Figure 2. The concentration of lactoferrin in 
the rowers was ~60% lower than control subjects at the start of the season (P=0.05, 
ES=0.68, ‘moderate’) and the midpoint (P=0.01, ES=0.89, ‘moderate’). While the 
difference was not significant at the end point of the study (P=0.12, ES=0.53, ‘small’) the 
concentration of salivary lactoferrin was half that of the control subjects. There were no 
significant temporal changes in the concentration of salivary lactoferrin in the rowers 
during the training period. While the concentration of salivary lactoferrin in both groups 
was characterized by large variation the rowers had a similar within-group variation 
(58%) compared to the control subjects (52%): ratio of CV=1.12. There was substantially 
greater between-group variation for the controls (107%) than the rowers (CV=77%) ratio 
of CV=0.73. There was no substantial difference in the concentration of albumin between 
the two groups. Correcting for albumin had little effect on the outcomes of the study. 
Mean concentration of lysozyme in saliva  
The mean concentration and standard error of the mean for salivary lysozyme for the 
rowers and control subjects is shown in Figure 3. There was a non-significant difference 
in the concentration of lysozyme throughout the study between rowers and controls. 
There was similar within-subject variability in the concentration of lysozyme in control 
subjects (67%) and rowers (71%, ratio of CV=1.06).  The between-group variations were 
also similar (controls 120%, rowers 109%, ratio of CV 0.90). Correcting for albumin had 
no effect on the results. 
Acute response of salivary lactoferrin and lysozyme to rowing ergometry 
There was a 50% increase in mean salivary lactoferrin concentration from pre-test 
(15.3±3.0µg.ml-1 mean ±SEM) to the maximal exertion step (30.2±5.1µg.ml-1) that was 
statistically significant (P=0.04, ES=1.04, ‘moderate’). There was no increase in the 
concentration of lactoferrin from pre-test to the submaximal step (15.6±5.1µg.ml-1, 
P=0.95) There was a significant linear increase (122%) in mean salivary lysozyme 
concentration from pre-test (13.5±3.8µg.ml-1) to post test (29.6±3.9µg.ml-1, P=0.01, 
ES=3.0, ‘large’). There was a non-significant (P=0.14) 60% increase in the concentration 
of lysozyme from pre-test to mid test (21.7±3.8 µg.ml-1). 
 
DISCUSSION 
This study found that elite rowers had approximately half the concentration of salivary 
lactoferrin and lysozyme than non-exercising control subjects over a five month training 
season. There was, however, no substantial temporal change in the concentration of these 
proteins in the rowers over the observation period. The concentrations of the proteins in 
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both studies were marked by large within subject (range 100-300%) and between group 
(range 50-150%) variations.   Humoral factors of the innate immune system are central to 
host resistance16. Lactoferrin and lysozyme play a complex role in host defence and there 
is little understanding of the way in which changes in their concentration affect 
susceptibility to upper respiratory tract infection in-vivo5, 17. These data indicate that 
prolonged intense rowing training lowers the concentration of a key salivary protein of 
innate mucosal immunity, which might leave individuals at greater risk of contracting 
illness and negatively impact training and competitive performance. 
 
In this study episodes and severity of illness were recorded.  However, there were too few 
illnesses reported over the observation period for any meaningful statistical analysis to be 
conducted.  A larger study, powered to determine differences in infections between the 
two groups, is required. 
 
Assessing a range of analytes, including differential cell counts, cell functional activity 
and both innate and adaptive humoral factors, may provide a more accurate picture of the 
way changes in immunity are associated with susceptibility to illness. Examining the 
variability of mucosal secretions of athletes in response to training and exercise may also 
hold promise in gaining a further understanding of the relationship between exercise, 
immunity and illness. The large variations in the concentrations of both the AMP proteins 
are consistent with studies of other mucosal immune parameters. Traditionally such large 
variability has been viewed as a limiting factor in determining the likelihood of detecting 
real change in the parameters being examined18.  Our findings indicate that regular 
physical exercise (athletic training) reduces the variability of both lactoferrin and 
lysozyme. A substantial difference in an individual’s variability from the group’s 
variability might be indicative of mucosal immune modulation and a subsequent change 
in susceptibility to illness19. Expanding the number of immune parameters examined may 
yield a simple test that can be used by athletes and coaches to provide further information 
on the immunological status of the athlete.  
 
Our inability to identify substantial temporal change in the concentration of salivary 
lactoferrin contrast with an earlier study that showed an initial sharp reduction at the 
onset of an exercise training period, which then remained low for the duration of the 
training period8. These contrasting findings may be due to the fact that in the current 
study the athletes had been training prior to the first sample being collected while in the 
earlier study the athletes began training after being enrolled. As such, the initial decline in 
salivary lactoferrin and lysozyme concentration may have already occurred. These 
disparate findings highlight the importance of understanding a subject’s recent training 
history when undertaking such studies. The stability in AMP concentration contrasts with 
the acute and chronic decreases described for salivary immunoglobulin A with prolonged 
intense exercise (SIgA)20. This difference may relate to the underlying immune regulation 
of antimicrobial peptides and the adaptation of the athletes to the training load. The 
persistent low basal concentrations of the proteins in this study may be a function of 
altered autonomic nervous system activity induced by twice daily exercise. There is 
strong involvement of the neuroendocrine system in the regulation of innate secretory 
immunity21. Prolonged intense exercise is associated with activation of the hypothalamic-
pituitary-adrenal axis and the secretion of glucocorticoids, with the exercise induced 
changes in the concentration of these neuropeptides persisting for several hours post 
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exercise. Increased secretion of glucocorticoids is associated with a reduction in salivary 
lysozyme concentration7. It is plausible that elevated cortisol levels in the post exercise 
period may be the underlying mechanism leading to reduced concentration of lactoferrin 
and lysozyme in saliva. Examining changes in salivary lactoferrin and lysozyme with 
other indices of stress and adaptation may yield further information about whether 
changes over a training period are related to the body’s ability to tolerate the exercise 
load. 
 
In contrast to the findings from the longitudinal study, there was a significant increase in 
the acute response of lactoferrin and lysozyme in response to a graded exercise test to 
exhaustion. The findings of an increase in salivary lactoferrin and lysozyme following 
maximal exertion exercise are consistent with a recent study that reported a 160% 
increase in salivary lysozyme concentration in response to both an acute exercise session 
at 75% VO2max and at maximal exertion7. Interestingly, we found that there was a non-
significant increase in the concentration of salivary lysozyme but not lactoferrin in 
response to a submaximal workload. This suggests that there may be an additive effect as 
the intensity of exercise increases on the concentration of salivary AMPs. It has been 
postulated that exercise-induced increases in the concentration of salivary AMPs are most 
likely related to sympathetic nervous system activity7. The increase in the concentration 
of these salivary proteins, particularly in response to maximal exertion exercise, may also 
have been the result of damage to epithelial cells through hyperventilation and 
subsequent exposure to environmental irritants, and the activation of neutrophils that then 
follows. Epithelial cells increase their expression of AMPs following physical damage22 
and contact with microbes23. It has also been postulated that increased concentration of 
AMPs following exhaustive exercise might confer improved immunity to infection. This 
view conflicts with the prevailing view, however, that immune competence is reduced 
and susceptibility to opportunistic infection increased immediately following prolonged 
exhaustive exercise24.  The findings of this acute study indicate that it is high intensity 
exercise of long duration that is more likely to lead to immune suppression in the post 
exercise period. 
 
In summary, this study provides evidence that elite rowers have chronically reduced 
concentrations of lactoferrin and lysozyme in the upper respiratory tract in comparison to 
their non-exercising counterparts. This study also found a transient activation response 
whereby AMPs increase in concentration in response to acute submaximal and maximal 
exertion exercise. The significance of the transient increase is yet to be determined. 
Future studies need to examine a range of exercise-induced changes to mucosal immunity 
and their effect on susceptibility to infection in a multi-factorial model. The use of a 
multifactorial model may provide insight into the way in which exercise-induced mucosal 
perturbation is related to susceptibility to illness. 
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What is already known on this topic? 
Salivary antimicrobial proteins (AMPs) have been proposed as markers of stress on the 
innate immune system. Contrasting findings have been reported on the effects of acute 
exercise on AMPs. No published work has examined the chronic effects of exercise on 
base concentrations of AMPs.  
 
What this study adds? 
Elite rowers have a ~50% lower concentration of salivary AMPs compared to sedentary 
individuals. There is large intra and inter-individual variability in the concentration of 
these proteins in both rowers and sedentary groups. More work is required to determine 
the clinical significance of lower salivary AMP concentration in athletes. 
 
 
FIGURE LEGENDS 
Figure 1: Schematic diagram showing the weekly training load undertaken by the 
rowers during the study. 
 
Figure 2: Salivary lactoferrin levels in rowers (■-■) and control (▲-▲) subjects.  
Values presented are the mean ± standard error of the mean.  P values 
indicate statistical significance at the commencement (baseline), midpoint and 
end of the study.   
 
Figure 3: Salivary lysozyme levels in rowers (■-■) and control (▲-▲) subjects.  
Values presented are the mean ± standard error of the mean.      
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